AB Science provides an update on the development of masitinib in progressive forms of multiple sclerosis post ECTRIMS 2024
PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE DEVELOPMENT OF MASITINIB IN PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS POST ECTRIMS…